Levy V, Miller C, Koeffler H P, Said J W
Department of Pathology and Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
Mod Pathol. 1996 Mar;9(3):245-8.
Lymphomas of mucosal-associated lymphoid tissues (MALT) constitute a distinct clinicopathologic entity comprised of centrocyte-like cells with a characteristic morphologic appearance and immunophenotype. The origin of these cells is still undetermined, although evidence suggests that they might derive from marginal zone lymphocytes present in normal lymph nodes and spleens. Recently, marginal zone lymphomas have been shown to have a high rate of p53 mutation. To determine whether p53 mutations were also present in MALT lymphoma, we evaluated specimens from eight patients (six gastric specimens, one parotid, and one from the small bowel) for p53 mutations using polymerase chain reaction and single strand conformational polymorphism analysis. Exon-4 through exon-8 were evaluated, because these are common sites of p53 mutation. In addition, tissues from 15 patients with MALT (including seven studied by single strand conformational polymorphism analysis) were examined for expression of p53 gene protein product by immunohistochemical techniques. All specimens were negative for p53 mutations, suggesting that mechanisms of lymphomagenesis are different for MALT than for splenic marginal zone lymphomas. Despite the absence of p53 point mutations, p53 gene product was localized in tissues from three of 15 patients with MALT. Staining was restricted to nuclei of neoplastic cells and was present in less than 10% of the cells. In summary, low-grade MALT lymphomas differ from marginal zone lymphomas in lacking p53 point mutations, although some patients express low levels of p53 gene product.
黏膜相关淋巴组织(MALT)淋巴瘤构成了一个独特的临床病理实体,由具有特征性形态外观和免疫表型的中心细胞样细胞组成。尽管有证据表明这些细胞可能源自正常淋巴结和脾脏中的边缘区淋巴细胞,但其起源仍未确定。最近,边缘区淋巴瘤已被证明具有较高的p53突变率。为了确定p53突变是否也存在于MALT淋巴瘤中,我们使用聚合酶链反应和单链构象多态性分析评估了8例患者(6例胃标本、1例腮腺标本和1例小肠标本)的标本中的p53突变情况。对第4外显子至第8外显子进行了评估,因为这些是p53突变的常见位点。此外,通过免疫组织化学技术检查了15例MALT患者的组织(包括7例通过单链构象多态性分析研究的患者)中p53基因蛋白产物的表达情况。所有标本的p53突变均为阴性,这表明MALT淋巴瘤的淋巴瘤发生机制与脾边缘区淋巴瘤不同。尽管没有p53点突变,但在15例MALT患者中的3例患者的组织中检测到了p53基因产物。染色仅限于肿瘤细胞的细胞核,且存在于不到10%的细胞中。总之,低度MALT淋巴瘤与边缘区淋巴瘤不同,缺乏p53点突变,尽管一些患者表达低水平的p53基因产物。